前列腺癌。一、组织化学检查在评估前列腺癌中的辅助作用。
Carcinoma of the prostate. I. Histochemical examination as an aid in evaluating prostate carcinoma.
作者信息
Vrubel F, Mráz J, Nĕmecek R, Papousek F, Hanselová M
出版信息
Int Urol Nephrol. 1979;11(4):295-9. doi: 10.1007/BF02086816.
PMID:536178
Abstract
In 26 patients with carcinoma of the prostate (CaP) the histochemical and histological characteristics of the tumour were compared with the clinical course in both untreated patients and in those receiving hormonal therapy. In the control group 16 patients with BPH were examined in the same way. It was found that histological types of CaP cannot be identified by grading. Higher frequency of very strong LDH activity in CaP was the only distinction against BPH.
摘要
对26例前列腺癌（CaP）患者的肿瘤组织化学和组织学特征与未治疗患者及接受激素治疗患者的临床病程进行了比较。对照组对16例良性前列腺增生（BPH）患者进行了同样的检查。结果发现，前列腺癌的组织学类型无法通过分级来确定。前列腺癌中乳酸脱氢酶（LDH）活性非常强的频率更高是与良性前列腺增生唯一的区别。
相似文献
1
Carcinoma of the prostate. I. Histochemical examination as an aid in evaluating prostate carcinoma.前列腺癌。一、组织化学检查在评估前列腺癌中的辅助作用。
Int Urol Nephrol. 1979;11(4):295-9. doi: 10.1007/BF02086816.
2
[Histochemical characterization of different tissue enzymes in prostate adenomas and carcinomas].[前列腺腺瘤和癌中不同组织酶的组织化学特征]
Acta Urol Belg. 1985;53(1):96-100.
3
Carcinoma of the prostate. II. Serum activity of acid phosphatase, prostatic acid phosphatase, LDH and its isoenzymes.前列腺癌。II. 酸性磷酸酶、前列腺酸性磷酸酶、乳酸脱氢酶及其同工酶的血清活性
Int Urol Nephrol. 1979;11(4):301-9. doi: 10.1007/BF02086817.
4
Histochemical and biochemical investigation of advanced prostatic carcinoma treated with estramustine phosphate, Estracyt.用磷酸雌莫司汀（癌腺治）治疗晚期前列腺癌的组织化学和生物化学研究
Scand J Urol Nephrol. 1973;7(1):18-22. doi: 10.3109/00365597309133665.
5
Prognostic usefulness of serum acid phosphatase levels in carcinoma of the prostate.血清酸性磷酸酶水平在前列腺癌中的预后价值
J Urol. 1974 Aug;112(2):237-40. doi: 10.1016/s0022-5347(17)59696-2.
6
[Histochemical examination as an aid in the evaluation of prostatic carcinoma].[组织化学检查在前列腺癌评估中的辅助作用]
Rozhl Chir. 1980 Dec;59(12):818-22.
7
[Histochemical enzyme studies of prostatic carcinoma influenced by therapy].[受治疗影响的前列腺癌组织化学酶研究]
Urol Int. 1971;26(1):77-93. doi: 10.1159/000279716.
8
[Histochemical enzyme studies on the differentiation of benign and malignant growths in the human prostate].[人体前列腺良性与恶性肿瘤分化的组织化学酶研究]
Urol Int. 1970;25(1):86-103. doi: 10.1159/000279665.
9
Prostatic carcinoma cured with hormonal treatment. A report of two cases.激素治疗治愈前列腺癌。两例报告。
Scand J Urol Nephrol. 1981;15(3):321-2.
10
LDH isoenzymes in benign and malignant prostate tissue. The LDH V-I ratio as an index of malignancy.良性和恶性前列腺组织中的乳酸脱氢酶同工酶。乳酸脱氢酶V-I比值作为恶性肿瘤指标。
Cancer. 1970 Apr;25(4):863-6. doi: 10.1002/1097-0142(197004)25:4<863::aid-cncr2820250416>3.0.co;2-r.
引用本文的文献
1
Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer.异常 FGFR 酪氨酸激酶信号通过重编程前列腺癌细胞中 LDH 同工酶的表达和活性增强了瓦博格效应。
Cancer Res. 2018 Aug 15;78(16):4459-4470. doi: 10.1158/0008-5472.CAN-17-3226. Epub 2018 Jun 11.
2
Carcinoma of the prostate. II. Serum activity of acid phosphatase, prostatic acid phosphatase, LDH and its isoenzymes.前列腺癌。II. 酸性磷酸酶、前列腺酸性磷酸酶、乳酸脱氢酶及其同工酶的血清活性
Int Urol Nephrol. 1979;11(4):301-9. doi: 10.1007/BF02086817.
本文引用的文献
1
Cytophotomeric DNA-analysis of aspirated cells from prostatic carcinoma.前列腺癌吸出细胞的细胞光度DNA分析
Acta Cytol. 1976 Jan-Feb;20(1):46-57.
2
Ultrastructural studies of human prostatic neoplasia.人类前列腺肿瘤的超微结构研究。
Cancer. 1976 May;37(5):2295-305. doi: 10.1002/1097-0142(197605)37:5<2295::aid-cncr2820370520>3.0.co;2-o.
Zotero 插件